South and Central America Biopharmaceutical Contract Manufacturing Market

The biopharmaceutical contract manufacturing market in South and Central America is expected to grow from US$ 564.89 million in 2021 to US$ 866.71 million by 2028; it is estimated to register a CAGR of 6.3% from 2021 to 2028.

The contract manufacturing organization (CMO) offers many benefits to pharmaceutical companies, including reducing investments in facilities and drug development costs, thereby improving net cash flow. Outsourcing is cheaper and enhances the efficiency of manufacturing processes. It allows pharmaceutical & biotechnology companies to redirect resources to other areas. In the past few years, the contract manufacturing industry was a niche service market offering more manufacturing capacity or specific services to pharmaceutical companies. The rise of CMOs was fueled by the rising number of drug manufacturing failures. Pharmaceutical companies undertook many manufacturing facilities to develop innovative drugs in the past. However, the demand for manufacturing outsourcing has continuously risen to reduce the risk of overcapacities. Moreover, several pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, further growing reliance on CMOS for manufacturing. Furthermore, the CMOs are vital in providing additional benefits to mitigate the risk of supply shortages by offering various sites for pharmaceutical companies with multisite supply strategies and backup capacities.

South and Central America Biopharmaceutical Contract Manufacturing Market Revenue and Forecast to 2028 (US$ Million)

South and Central America Biopharmaceutical Contract Manufacturing Market Segmentation     

South and Central America Biopharmaceutical Contract Manufacturing Market – By Product

• Biologics
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Others
• Biosimilar

South and Central America Biopharmaceutical Contract Manufacturing Market – By Service

• Process Development
  • Downstream Processing
  • Upstream Processing
• Fill and Finish Operation
• Analytical and QC Studies
• Packaging

South and Central America Biopharmaceutical Contract Manufacturing Market – By Source

• Mammalian
• Microbial-Based Biologics/ Non-Mammalian

South and Central America Biopharmaceutical Contract Manufacturing Market– By Country

• Brazil
• Argentina
• The Rest of South and Central America

South and Central America Biopharmaceutical Contract Manufacturing Market-Companies Mentioned

• AbbVie Inc.
• Ajinomoto Co. Inc
• Boehringer Ingelheim International GmbH
• General Electric Company
• Lonza
• MERCK KGAA
• Samsung Biologics
• THERMO FISHER SCIENTIFIC INC

South and Central America Biopharmaceutical Contract Manufacturing Market Strategic Insights

South and Central America Biopharmaceutical Contract Manufacturing Market Segmentation Analysis

South and Central America Biopharmaceutical Contract Manufacturing Market Report Highlights

South and Central America Biopharmaceutical Contract Manufacturing Report Scope

South and Central America Biopharmaceutical Contract Manufacturing Market Country and Regional Insights